The effect of null C4 alleles on complement function.
C4 is encoded at two polymorphic genetic loci (C4A and B), and "null" or unexpressed alleles are relatively common. An increased frequency of nulls has been reported in a variety of diseases. In the present study, C4 allotypes and C4 hemolytic efficiencies (the ratios of functional to antigenic levels) were determined for a population of 75 normal unrelated individuals. Of these, 28 had three gene products (single null at C4A or B) while three had no expressed C4A products and three had no C4B products (homozygous null). Mean antigenic C4 levels correlated with the number of expressed gene products but there was a wide spread of individual values. Those homozygous null for C4A had greater, and for C4B less, hemolytic efficiency than those with four gene products. However, there was no difference in the in vitro kinetics of C3 convertase formation between homozygous null C4A or C4B individuals. Therefore, the presence of null genes for C4 does not appear to compromise complement function sufficiently to account for the reported disease associations. Some of the associations may result from the fact that null genes for C4, as part of an extended HLA haplotype, may be genetically linked to disease susceptibility.
D000328:Adult; D000483:Alleles; D000818:Animals; D050577:Complement C3-C5 Convertases / Q000378:metabolism; D003181:Complement C4 / Q000235:genetics* / Q000502:physiology; D003165:Complement System Proteins / Q000378:metabolism; D005787:Gene Frequency; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D007519:Isoantigens / Q000235:genetics; D007700:Kinetics; D014176:Protein Biosynthesis
D003181:Complement C4; D007519:Isoantigens; D003165:Complement System Proteins; D050577:Complement C3-C5 Convertases